These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
389 related items for PubMed ID: 541735
1. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit. Gibson RE, Eckelman WC, Vieras F, Reba RC. J Nucl Med; 1979 Aug; 20(8):865-70. PubMed ID: 541735 [Abstract] [Full Text] [Related]
2. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Luthin GR, Wolfe BB. Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291 [Abstract] [Full Text] [Related]
3. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport. Zimmerman TW, Binder HJ. Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277 [Abstract] [Full Text] [Related]
4. Comparison of the affinity constant of some muscarinic receptor antagonists with their displacement of [3H]quinuclidinyl benzilate binding in atrial and ileal longitudinal muscle of the guinea-pig. Choo LK, Mitchelson FJ. J Pharm Pharmacol; 1985 Sep; 37(9):656-8. PubMed ID: 2867189 [Abstract] [Full Text] [Related]
5. Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptors. Gibson RE, Rzeszotarski WJ, Eckelman WC, Jagoda EM, Weckstein DJ, Reba RC. Biochem Pharmacol; 1983 Jun 15; 32(12):1851-6. PubMed ID: 6882462 [Abstract] [Full Text] [Related]
6. Use of 3-quinuclidinyl 4-iodobenzilate as a receptor binding radiotracer. Eckelman WC, Eng R, Rzeszotarski WJ, Gibson RE, Francis B, Reba RC. J Nucl Med; 1985 Jun 15; 26(6):637-42. PubMed ID: 3998853 [Abstract] [Full Text] [Related]
7. In vivo competition studies with analogues of 3-quinuclidinyl benzilate. Eckelman WC, Grissom M, Conklin J, Rzeszotarski WJ, Gibson RE, Francis BE, Jagoda EM, Eng R, Reba RC. J Pharm Sci; 1984 Apr 15; 73(4):529-34. PubMed ID: 6327965 [Abstract] [Full Text] [Related]
8. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. Watson M, Roeske WR, Yamamura HI. J Pharmacol Exp Ther; 1986 May 15; 237(2):419-27. PubMed ID: 3754581 [Abstract] [Full Text] [Related]
9. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate. Aguilar JS, Salas PJ, De Robertis E. Mol Pharmacol; 1982 Sep 15; 22(2):304-9. PubMed ID: 7144732 [No Abstract] [Full Text] [Related]
10. In vivo characterization of myocardium muscarinic receptors by positron emission tomography. Mazière M, Comar D, Godot JM, Collard P, Cepeda C, Naquet R. Life Sci; 1981 Dec 07; 29(23):2391-7. PubMed ID: 6976499 [No Abstract] [Full Text] [Related]
11. Cholinergic muscarinic receptors in rat myocardium: properties of [3H]quinuclidinyl benzilate [QNB] binding sites. Mittal CK. Indian J Exp Biol; 1985 Jun 07; 23(6):300-5. PubMed ID: 4077129 [No Abstract] [Full Text] [Related]
12. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. Bloom JW, Halonen M, Lawrence LJ, Rould E, Seaver NA, Yamamura HI. J Pharmacol Exp Ther; 1987 Jan 07; 240(1):51-8. PubMed ID: 3806397 [Abstract] [Full Text] [Related]